1 Interventional Medical Center, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China 2 Department of Internal Medicine, Qingdao Cardiovascular Hospital, Qingdao, Shandong, China ...
All combination treatments, including TACE with RFA, MWA, HIFU, PEI, or RT, significantly improved both 1-year and 2-year survival rates compared to TACE alone. Combination therapies, particularly ...
Combining TACE and SBRT offers a promising treatment for large HCC tumors, addressing TACE's limitations in intermediate-stage cases. Technological advancements have improved SBRT's precision and ...
TOKYO, Jul 29, 2025 - (JCN Newswire) - - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that its in-house discovered tyrosine kinase inhibitor, "LENVIMA(R)" (generic ...
In this review we will discuss TACE, TAE and TOCE in detail. The TACE procedure consists of the injection of anticancer drugs mixed with or without lipiodol into the hepatic artery followed by the ...
Background: Hepatocellular carcinoma (HCC) is a major cancer challenge worldwide. Combination therapy using transcatheter arterial chemoembolization (TACE) and percutaneous ablation offers potential ...
Tick marks indicate censoring of data. No participants had an albumin-bilirubin grade of 3, so this group has not been included in subgroup definitions here. BCLC=Barcelona Clinic Liver Cancer.
Lenvima plus Keytruda with TACE significantly improved progression-free survival in unresectable, non-metastatic hepatocellular carcinoma compared to TACE with placebo. The study reported a median ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback